Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Covidien was a leading global healthcare products company specializing in the development and manufacture of medical devices and supplies. Originally the healthcare division of Tyco International, it was spun off as an independent public entity in 2007 before being acquired by Medtronic in 2015 for approximately $43 billion. The company's extensive portfolio included industry-standard technologies for surgical stapling, vessel sealing, patient monitoring, and airway management. Covidien International Finance S.A. served as the primary financing arm for the organization, managing debt issuance and capital structure. Following the acquisition, Covidien's operations were integrated into Medtronic's Minimally Invasive Therapies Group, significantly expanding Medtronic's global footprint in the surgical space. The legacy of Covidien remains central to modern surgical suites through widely used brands like LigaSure and Tri-Staple.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Covidien International Finance.